- Japan approved ¥631.5 billion ($4 billion) in additional subsidies for Rapidus Corp. on April 11, 2026, per Bloomberg, bringing cumulative public support to approximately ¥2.5 trillion ($16 billion).
- Rapidus, founded in 2022, is targeting 2-nanometer chip production at its Chitose, Hokkaido facility by 2027 using extreme ultraviolet lithography and IBM Research process technology.
- Industry analysts have consistently described the Rapidus timeline as one of the most aggressive in modern semiconductor history, given Japan’s roughly 30-year absence from leading-edge fabrication.
- The funding escalation places Japan’s total Rapidus commitment in the same tier as U.S. CHIPS Act spending, though unlike TSMC’s Arizona expansion, Rapidus is building capacity from scratch.
What Happened
Japan’s government approved ¥631.5 billion ($4 billion) in new subsidies for Rapidus Corp. on April 11, 2026, according to Bloomberg, pushing the country’s total public investment in the AI chip startup to approximately ¥2.5 trillion — equivalent to roughly $16 billion at current exchange rates. The disbursement is intended to accelerate Rapidus’s push into the market for advanced logic chips used in AI training and inference workloads. Rapidus was established in 2022 as a consortium-backed venture involving eight major Japanese corporations — including Toyota, Sony, SoftBank, NTT, NEC, Denso, Kioxia, and Mitsubishi UFJ Financial Group — alongside Japan’s Ministry of Economy, Trade and Industry (METI).
Why It Matters
The decision intensifies a global subsidy race for advanced semiconductor manufacturing. The United States committed approximately $52 billion to domestic chip production through the 2022 CHIPS and Science Act; South Korea’s government has backed domestic chip investment with a comparable legislative package. Japan’s cumulative Rapidus commitment now places it among the largest single-nation bets on a new chipmaker. Rapidus CEO Atsuyoshi Koike has stated publicly that if the company fails to achieve mass production by 2027, “the dream is over” — a characterization that reflects the project’s high-stakes structure as a government-directed industrial policy effort rather than a commercially self-funded startup.
Technical Details
Rapidus is constructing its first integrated manufacturing facility, designated IIM-1, in Chitose, Hokkaido. The fab targets the 2-nanometer process node, which requires extreme ultraviolet (EUV) lithography — the same class of equipment TSMC deployed for its N2 process, which entered risk production in 2024. Rapidus holds a technology collaboration agreement with IBM Research, under which IBM’s 2nm chip architecture and process development methodology serve as the technical foundation for Rapidus’s production ramp. The company stated it aimed to produce pilot test chips in 2025 ahead of high-volume manufacturing in 2027 — a two-year commercial ramp that analysts at firms including TechInsights have described as extraordinarily compressed for a greenfield fab with no prior advanced-node production history.
Who’s Affected
The immediate beneficiaries of the new funding are Rapidus’s approximately 1,000 employees and its equipment supply chain, which includes Dutch EUV machine maker ASML, U.S. firm Applied Materials, and Tokyo Electron, one of Japan’s largest semiconductor equipment manufacturers. For AI chip designers and hyperscale cloud providers evaluating geographic supply-chain diversification away from Taiwan, Rapidus’s production timeline is a direct input into procurement planning. NTT and SoftBank have been identified as prospective early customers; sustained schedule delays would extend the period during which AI chip supply remains concentrated in Taiwan, a supply-chain risk calculation that frames much of the project’s government backing.
What’s Next
METI is expected to attach performance milestones to the new ¥631.5 billion disbursement, which will provide the most concrete public benchmark against which Rapidus’s progress can be tracked. Whether the company’s previously stated 2025 pilot-production target was met will be an early indicator of whether the 2027 commercial deadline is still viable. Bloomberg described the project as “widely regarded as a long shot,” a characterization that will be tested as IIM-1 construction progresses and equipment installation timelines become public.
